In particular, haptoglobin has been studied further in the present Nigerian cohort [2], showing overall depleted levels in severe malaria groups and the data supporting the idea that low haptoglobinaemia is a risk factor in SMA but not CM. This evidence concerns the gene HP and cutaneous mastocytosis.